Efficacy of Bevacizumab combined with EX-PRESS in the treatment of refractory glaucoma

Journal Title: Guoji Yanke Zazhi - Year 2018, Vol 18, Issue 4

Abstract

AIM:To investigate the efficacy of Bevacizumab intravitreal injection combined with EX-PRESS in the treatment of refractory glaucoma. <p>METHODS: The research objects were 150 cases(150 eyes)of patients with refractory glaucoma from June 2014 to December 2016 in our hospital. All patients were treated with EX-PRESS glaucoma drainage device implantation, and their medicine data were analyzed retrospectively. Totally 70 cases(70 eyes)were treated with EX-PRESS only were set as the control group; 80 cases(80 eyes)received bevacizumab intravitreal injection on the basis of the treatment of the control group were set as the observation group. The successful rate of operation was evaluated, the intraocular pressure was measured before operation and at 7d, 1, 3, 6mo after treatment by non-contact conometer, followed by record of the visual acuity and complications before and after 6mo of treatment. <p>RESULTS: The observation group's total surgical success rate was 72.5%, which was sharply higher than that of the control group(58.6%); while the partial success rate was 17.5%, which was significantly lower than that of the control group(30.0%), with statistical significance(<i>χ</i><sup>2</sup>=5.453, <i>P</i>=0.028; <i>χ</i><sup>2</sup>=4.213, <i>P</i>=0.047). Two groups' surgical failure rate had no distinct difference(<i>χ</i><sup>2</sup>=0.000, <i>P</i>=1.000). There was no significant difference in visual acuity of the two groups before and after operation(<i>P</i>>0.05). There was no significant difference in intraocular pressure between the two groups(<i>F</i><sub>groups</sub>=982.27, <i>P</i><0.05; <i>F</i><sub>time</sub>=941.88, <i>P</i><0.05). The intraocular pressure of the two groups decreased significantly after treatment, and at the 7d observation group was significantly higher than that of the control group after operation(<i>P</i><0.05). After 1, 3, 6mo of operation, there was no abvious difference between two groups on IOP(<i>P</i>>0.05). The observation group's low intraocular pressure, anterior chamber bleeding and shallow anterior chamber incidence were significantly lower than those of the control group, there was statistical meaning(<i>P</i><0.05). <p>CONCLUSION: Intravitreal injection of bevacizumab combined with EX-PRESS in the treatment of refractory glaucoma can improve the complete success rate, as well as perform effective control on complications such as short-term intraocular pressure, hyphema, low intraocular pressure.

Authors and Affiliations

Qian Wang

Keywords

Related Articles

Scleral buckling-induced ocular parameter changes in patients of rhegmatogenous retinal detachment

AIM: To evaluate the ocular parameter changes following scleral buckling(SB)for rhegmatogenous retinal detachment(RRD). <p>METHODS: This retrospective, non-randomized case-control study included 46 eyes of 23 patients wh...

Establishment of rat model of retinal branch vein occlusion by photochemical method and correlational research

AIM:To investigate the natural course and adverse event of branch retinal vein occlusion(BRVO)rat model induced by laser photochemical method.<p>METHODS: Thirty SD(Sprague Dawley)rats were administrated Bangladesh <i>via...

Research progress on related factors of dry eye in children

As one of the most common diseases, dry eye in adults has been extensively investigated in the past decades. However, research on dry eye in children are very limited, leading to missed diagnosis or poor treatment in cli...

Anti-VEGF medicine with PRP for neovascular glaucoma

AIM:To investigate the effect of anti-vascular endothelial growth factor(VEGF)combined with pan retinal photocoagulation(PRP)on neovascular glaucoma(NVG)and its effect on VEGF and platelet-derived growth factor-C(PDGF-C)...

Clinical significance of reopening anterior chamber angle for severe acute angle-closure glaucoma

AIM: To explore whether the drainage angle could be reopened by surgery in patients with severe acute angle-closure glaucoma at “the greatest degree” of angle closure, and to study the treatment methods, such as double-p...

Download PDF file
  • EP ID EP656148
  • DOI 10.3980/j.issn.1672-5123.2018.4.21
  • Views 115
  • Downloads 0

How To Cite

Qian Wang (2018). Efficacy of Bevacizumab combined with EX-PRESS in the treatment of refractory glaucoma. Guoji Yanke Zazhi, 18(4), 678-681. https://europub.co.uk/articles/-A-656148